Oncology CoPilot
Our focus today
'Cancer' is the broadest term encapsulating myriad ailments. There is no single cure. Each cancer type has its own unique challenges and treatment options.
Pancreatic Cancer
The challenges of Pancreatic Cancer
Pancreatic cancer is a complex and aggressive disease with limited treatment options. Timelines are compressed for myriad reasons, from late stage discovery to the aggressive nature of the disease's progression. The standard of care today typically involves beginning a therapy regimen with limited information. Therapy options are limited and generally must be started before more comprehensive test results are made available.
How we're tackling these issues
Precision AI Solutions has partnered with Cellentia to expedite tumor analysis and reduce RNAseq processing time. We can turn the time between biopsy and test result from weeks into days. The Oncology CoPilot platform can analyze these results and provide personalized treatment recommendations with greater efficacy and minimizing patient risk. These assessments have a global impact as well. Better therapy recommendations don't just benefit the individual patient, but also the entire population. As we learn more about what works, research will yield new therapy recommendations by having a clearer understanding of what is effective and how to keep patients comfortable.
Triple Negative Breast Cancer (TNBC)
Why TNBC stands out amongst breast cancer diagnoses
Breast cancer is one of the most common cancers. A litany of research and treatment options exist for many breast cancer subtypes. Triple Negative Breast Cancer (TNBC) is a particularly aggressive form of breast cancer that lacks the three most common types of receptors known to fuel most breast cancer growth. This makes it more difficult to treat, as many of the targeted therapies used for other breast cancers are ineffective against TNBC. As a result, TNBC often requires more aggressive treatment approaches, such as chemotherapy, which can have significant side effects and impact on quality of life.
What we hope to bring to the table
Oncology CoPilot's unique approach to tumor cell analysis goes beyond the traditional scope of using biomarkers and select coding genes to identify effective therapies. Instead, we leverage the full breadth of the molecular landscape to identify the most effective therapies for each patient, analyzing all genes.